Long-Term Efficacy and Safety of Everolimus as Adjunctive Therapy in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: Final Analysis of the Exist-3 Study
Yazar
Pelov, D.
Mookerjee, B.
Peyrard, S.
French, J.
Yapici, Z.
Polster, T.
Franz, D. N.
Lawson, J. A.
Ikeda, H.
Nabbout, R.
Curatolo, P.
de Vries, P. J.
Dlugos, D.
Fan, J.
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]